The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/36380
StudyName: Eligibility Metastatic Breast Cancer NCT01989676
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 08.05.2019
License: Creative Commons BY 4.0

----

Description: 
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02); ODM derived from: https://clinicaltrials.gov/show/NCT01989676
